Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2002
10/03/2002US20020142051 Hydrogen peroxide disinfectant with increased activity
10/03/2002US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002US20020142041 Gastrointestinal mucosa-adherent matrixes, pharmaceutical preparations and a coating composition
10/03/2002US20020142011 Vaccine
10/03/2002US20020141987 Fish serine proteinases and their pharmaceutical and cosmetic use
10/03/2002US20020141977 Immunotherapy based on dendritic cells
10/03/2002US20020141972 Administering protein and antiinflection agent
10/03/2002US20020141971 Administering by tissue absorption
10/03/2002US20020141970 Stabilized with chelate compound; storage stability
10/03/2002CA2442178A1 2-amino-propanol derivatives
10/03/2002CA2442004A1 Microbial feeds for aquaculture and agriculture
10/03/2002CA2441824A1 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition
10/03/2002CA2441809A1 Lipsomal vaccines comprising dilipopetides for modulating t1 and t2 immune responses
10/03/2002CA2441790A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002CA2441763A1 Prognostic methods for breast cancer
10/03/2002CA2441663A1 Viral vectors and their use in therapeutic methods
10/03/2002CA2441588A1 Use of cytokines of the tgf-.beta. superfamily for the treatment and diagnosis of skin related disorders
10/03/2002CA2441551A1 Pathogenic and commensal vaccine antigens
10/03/2002CA2441520A1 Methods for the treatment of hiv and other viruses
10/03/2002CA2441287A1 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
10/03/2002CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002CA2439961A1 Human cytokine receptor
10/03/2002CA2439678A1 Uses of opg ligand to modulate immune responses
10/03/2002CA2439431A1 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002CA2436208A1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor
10/03/2002CA2434020A1 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/02/2002EP1245678A2 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
10/02/2002EP1245677A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
10/02/2002EP1245673A2 Efficient genetic suppressor elements
10/02/2002EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
10/02/2002EP1245567A1 HIV inhibiting pyrimidine derivatives
10/02/2002EP1245566A1 Quinolin-4-one derivatives and their use as antibiotics
10/02/2002EP1245236A1 Preventives and remedies for chronic hepatitis
10/02/2002EP1245235A2 Method for extracting oleaginous substances from ganoderma lucidum spores
10/02/2002EP1245231A2 Pharmaceutical formulations containing darifenacin
10/02/2002EP1245230A2 Amentoflavone as an antiviral agent
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1244807A1 Il-6 like polynucleotide
10/02/2002EP1244798A2 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244789A2 Genes identified as required for proliferation of e. coli
10/02/2002EP1244773A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
10/02/2002EP1244701A1 Transferrin polynucleotides, polypeptides, and antibodies
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244668A1 Purine derivatives, process for their preparation and use thereof
10/02/2002EP1244651A1 Diamidine compounds as dna minor groove binders
10/02/2002EP1244649A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244648A1 Chemokine receptor binding heterocyclic compounds
10/02/2002EP1244641A1 Thiazolyl amide derivatives
10/02/2002EP1244629A2 Quinolone compounds for use in treating viral infections
10/02/2002EP1244627A1 Picolinic acid derivatives and their use as fungicides
10/02/2002EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002EP1244624A1 Anthracene derivatives as anti-cancer agents
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002EP1244616A1 (hetero)bicyclylmethanesulfonylamino-substituted hydroxamic acid derivatives
10/02/2002EP1244471A1 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
10/02/2002EP1244470A2 Use of heat shock proteins to enhance production of chemokines by a cell
10/02/2002EP1244466A2 Activation and inhibition of the immune system
10/02/2002EP1244463A1 Agent which is anti-adhesive in relation to the pathogenic flora of the skin
10/02/2002EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002EP1244459A2 Treatment of drug-resistant human immunodeficiency virus infection
10/02/2002EP1244444A1 Process for formulation of carbapenem antibiotic compositions
10/02/2002EP1244443A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject
10/02/2002EP1244439A1 Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage
10/02/2002EP1244434A2 Use of chemotherapeutic agents
10/02/2002EP1244432A2 Methods for pulmonary delivery of interleukin-2
10/02/2002EP1244359A1 Combination of n-phenyl-n'-benzoyl urea derivative and nectin compounds for parasite control
10/02/2002EP1244356A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
10/02/2002EP1139762B1 Hydrogen peroxide disinfectant with increased activity
10/02/2002EP1077068B9 Utilization of interferon alpha 5 in the treatment of viral hepatopathies
10/02/2002EP1007062A4 Therapeutic use of hemoglobin to treat head injury
10/02/2002EP0989851B1 Self-emulsifying formulation for acidic lipophilic compounds
10/02/2002EP0923594B1 Bromotiacumicin compounds
10/02/2002EP0896532B1 Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals
10/02/2002EP0871465B1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids
10/02/2002EP0839035B1 Antifungal agent, compound therefor, process for producing the same
10/02/2002EP0717750B1 Double-stranded peptide nucleic acids
10/02/2002EP0706521B1 Imides as tnf alpha inhibitors
10/02/2002DE10114364A1 Verfahren zur Herstellung von antibiotischen Kompositen A process for producing antibiotic composites
10/02/2002DE10114138A1 Cdk-inhibitorische Indirubinderivate mit erhöhter Löslichkeit Cdk-inhibitory indirubin derivatives with increased solubility
10/02/2002DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution
10/02/2002CN1372598A Methods of inducing cell death
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372566A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/02/2002CN1372560A Crystalline 1-methylcarbapenem compounds
10/02/2002CN1372473A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/02/2002CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease
10/02/2002CN1372465A Antimycotic drug
10/02/2002CN1372464A Naphthoquinone derivatives and their use in the treatment and control of tuberculosis
10/02/2002CN1372462A Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system
10/02/2002CN1371903A Optical isomer of 3-methyl fentanyl, derivant, synthesizing and its analgesic activity
10/02/2002CN1371749A Biological therapy adjuvant originated from animal Chinese medicine
10/02/2002CN1371748A Zhonghua soft-shelled turtle aeromonad oral slow-releasing microsphere vaccinum and preparation process thereof
10/02/2002CN1371747A Anti-HIV medicine
10/02/2002CN1371737A Chinese medicine specially effective for liver disease and preparation process
10/02/2002CN1371734A Ointment capable of quick sterilizing AIDS, veneral virus and spermatozoa and preparation process thereof
1 ... 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 ... 1798